Greencare Capital plc’s shares will be traded on the AQUIS Stock Exchange (formerly NEX) from 30 December 2019.
The Greencare Capital ticker code is GRE
ISIN CODE: GB00BJBYK814
Enlarged number of Ordinary Shares of 1 pence each in issue following Admission: 12,057,374
Subscription price: 25 pence
Market Capitalisation at the Subscription price on Admission: £3,014,334
Number of Shares held in public hands: 2,057,374
To view Greencare Capital plc’s share price and latest trades please click here
No securities are held as treasury shares.
There are no restrictions on the transfer of shares.
The Company’s main country of operation is The United Kingdom. The Company is Incorporated and registered in England and Wales with registered number 12237710
Greencare Capital plc is subject to the City Code on Takeovers and Mergers.
The Directors are also committed to maintaining high standards of Corporate Governance and propose, as far as practicable, given the Company’s size and nature, to comply with the QCA Code.
As at the date of Admission to AQUIS Stock Exchange (formerly NEX) and as far as the directors are aware, the following shareholders are interested in 3% or more of the Company’s issued share capital.
There are no outstanding share options.
At the date of Admission, the Company will have issued warrants over Ordinary Shares as follows:
*issued on a pro-rata basis
The terms of the warrants are identical and provide for a 5 year exercise period at the Subscription Price. The warrants are freely transferable.
There are over 100 active compounds contained in Cannabis plants, with cannabinoids and terpenes being the two largest groups. Two cannabinoids are the most significant of these compounds:
It is the terpenes in Cannabis which are responsible for its strong smell.
In the United Kingdom THC and other cannabinoids are deemed controlled substances under the MDA 1971, while CBD is not deemed to be a controlled substance.
The Cannabis market has four distinct categories:
In addition to the Cannabis market, there is also a substantial Hemp industry which has four main product groups; fibres, shivs, pharmaceuticals and seeds.